相关实验视频
Updated: Jun 15, 2025

06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
133
德菲拉西洛克斯纳米悬浮装载溶解微针用于眼部药物输送
Hafsa Shahid Faizi1, Muhammad Iqbal Nasiri2, Yu Wu3
1School of Pharmacy, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, United Kingdom; College of Pharmacy, University of Sargodha, University Road, Sargodha, Punjab 40100, Pakistan.
International journal of pharmaceutics
|August 21, 2024
概括
装入微针的deferasirox (DFS) 纳米悬浮为治疗视网膜疾病提供了一种不那么侵入性的方法. 这种新方法改善了药物的溶解性和向眼睛的输送,增强了神经保护.
科学领域:
- 眼科医生 眼科 眼科
- 纳米技术 纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 德费拉西洛克斯 (DFS) 是一种口服铁化剂,具有神经保护性,有利于治疗视网膜疾病,如与年龄相关的黄斑变性 (AMD).
- 传统的口服DFS面临挑战,包括频繁的剂量和第一通代谢.
- 微针 (MNs) 提供了一个微侵袭的替代方案,用于内药物输送,可能克服口服和内途径的局限性.
研究的目的:
- 开发和评估装入纳米悬浮 (NS) 的deferasirox (DFS),并将其纳入聚合物溶解微针 (MN) 中,用于眼部药物输送.
- 评估DFS-NS装载微针 (DFS-NS-OcMNs) 的溶解性,稳定性,机械性能和眼组织透率.
- 评估DFS-NS-OcMNs的安全性和有效性,用于将DFS输送到眼睛的后部.
主要方法:
- 通过使用聚乙醇 (PVA) 作为稳定剂的湿媒磨,DFS被制成纳米悬浮 (NS).
- DFS-NS被装入聚合物溶解微针 (OcMNs) 中.
- 评估了溶解性,稳定性 (通过TGA进行短期和热),机械强度,膜透 (OCT成像),药物沉积 (膜沉积研究) 和细胞活力 (ARPE细胞).
主要成果:
- 与纯粹的DFS相比,DFS-NS显示溶解度增加了4倍.
- DFS-NS-OcMNs显示出足够的机械强度来穿透膜,其中81.23 ± 7.35%的MN高度被插入猪膜.
- 膜沉积研究显示,DFS-NS-OcMNs在5分钟内沉积了64%的药物,几乎是纯DFS-OcMNs的5倍.
- 无论是DFS还是DFS-NS-OcMN,都在人类视网膜色素 (ARPE) 细胞上表现出良好的细胞活力.
结论:
- 将DFS制成纳米悬浮剂显著提高了其溶解性和稳定性.
- 装有DFS-NS的聚合物溶解微针提供了一种有效和最少的侵入性方法,用于将DFS输送到眼睛后部.
- DFS-NS-OcMNs显示出作为用于治疗视网膜疾病的传统DFS输送方法的安全和有效替代品的潜力.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
766
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
766
Drug Delivery: Miscellaneous Routes
329
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
329
Drug Delivery: Parenteral Route
447
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
447

